The cancellation of a Cipla unit's drug sale licence by the Maharashtra FDA, a GST search at Sudarshan Chemical Industries, and a 25% rise in Bajaj Housing Finance's assets under management lead the list of stocks in focus on Monday, October 5.
Regulatory and legal
- Cipla: The Maharashtra FDA has cancelled a company unit's drug sale licence over alleged violations, according to a newspaper report. The company has not issued a disclosure on the matter at the time of writing.
- Sudarshan Chemical Industries: Maharashtra GST officials have conducted a search at the company's offices and manufacturing units under Section 67.
Results and business updates
- Bajaj Housing Finance: Gross disbursements in the second quarter of FY27 reached ₹19,930 crore, against ₹15,914 crore in the same quarter last year. Assets under management grew 25% to ₹1,58,190 crore, and loan assets rose to ₹1,39,850 crore.
- Sai Silks (Kalamandir): Second quarter FY27 turnover stood at ₹434 crore. The company opened four new stores across Karnataka and Andhra Pradesh.
- Sedemac Mechatronics: Reported its highest quarterly sales of control-intensive ECUs at 1,452,867 units, up 37.5% year on year. Cumulative sales o...